QA: Paratek Pharmaceuticals Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2021_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 164,117,000
1 IntangibleAssetsNetIncludingGoodwill 829,000
2 PropertyPlantAndEquipmentNet 964,000
3 remainder_Assets 10,943,000
4 LiabilitiesCurrent 23,953,000
5 LiabilitiesNoncurrent 255,160,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 34,455,115
8 SellingGeneralAndAdministrativeExpense 90,617,303
9 ResearchAndDevelopmentExpense 18,768,305
10 remainder_Expenses 26,962,054
11 remainder_Revenues 44,240,949
12 remainder_NetIncome 206,319
13 remainder_ComprehensiveNetIncome 22,584
  yvar yval
0 Assets 176,853,000
1 Liabilities 279,113,000
2 Expenses 170,802,777
3 Revenues 44,240,949
4 StockholdersEquity -102,260,000
5 NetIncome -126,355,509
6 ComprehensiveNetIncome -126,344,217
7 BaseVar 335,619,314
8 EconomicCapitalRatiobeforeLimitedLiability -1.53
9 EconomicCapitalRatio 1.17

Edgar->Model Mapping

Feature Distribution

Change over Time